Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedRecruitment status updated to no longer look for participants, signaling enrollment closure. A new revision tag v3.6.0 was added and the previous tag v3.5.5 was removed.SummaryDifference0.4%

- Check9 days agoChange DetectedA new revision entry 'Revision: v3.5.5' is added to the study record history, replacing the previous 'Revision: v3.5.4'. This reflects an updated revision of the ClinicalTrials.gov page history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new site revision entry, v3.5.4, was added to the record history, replacing the previous revision v3.5.3. This indicates a small update to the page's backend/metadata rather than content changes.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer/update indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software version change rather than a change to the clinical trial record.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3; this change updates revision metadata only.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.